Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004644077 | SCV005145890 | uncertain significance | not specified | 2024-06-05 | criteria provided, single submitter | clinical testing | The c.13G>T (p.G5W) alteration is located in exon 1 (coding exon 1) of the NPEPL1 gene. This alteration results from a G to T substitution at nucleotide position 13, causing the glycine (G) at amino acid position 5 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |